Jeroen Roosendaal

6PUBLICATIONS
0CO-AUTHORS
Toxicology (incl. clinical toxicology)Neurosciences not elsewhere classifiedMedical virologyImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Development and validation of a multi-matrix LC-MS/MS method for quantification of 20 drugs in human postmortem and porcine surrogate matrices.

|Feb 09, 2026
Toxicological interpretation of N-ethylpentedrone and its metabolites in 12 fatal and non-fatal forensic cases.

Jeroen Roosendaal, Ingrid J Bosman, Pieter M I Van Driessche

|Jun 14, 2023
A fatal mono-intoxication with 4-fluoroisobutyrylfentanyl: Case report with postmortem concentrations.

Jeroen Roosendaal, Roelof Oosting, Dick-Paul Kloos

|May 21, 2020
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose.

Jeroen Roosendaal, Stefanie L Groenland, Hilde Rosing

|May 09, 2020
Phase I pharmacological study of continuous chronomodulated capecitabine treatment.

Jeroen Roosendaal, Bart A W Jacobs, Dick Pluim

|Oct 13, 2019
Mass balance and metabolite profiling of 14C-guadecitabine in patients with advanced cancer.

Jeroen Roosendaal, Hilde Rosing, Luc Lucas

Pageof 1

Frequent Collaborators